Related Experiment Video
Updated: Jun 5, 2026
10:31
Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
Occupational hepatic disorders in Korea.
Hyoung Ryoul Kim1, Tae Woo Kim
1Department of Preventive Medicine and Industrial Medical Center, The Catholic University of Korea, College of Medicine, Seoul, Korea. cyclor@catholic.ac.kr
Journal of Korean Medical Science
|January 25, 2011
Summary
Occupational hepatic disorders in Korea include toxic hepatitis from chemical exposure and viral hepatitis in healthcare workers. Preventive measures like medical exams, vaccinations, and monitoring are crucial for worker health and preventing liver disease.
Area of Science:
- Occupational Medicine
- Hepatology
- Toxicology
Background:
- Occupational hepatic disorders are a significant concern in Korea, categorized into toxic hepatitis, viral hepatitis, and chemical-induced malignancy.
- Specific chemicals like dimethylformamide, dimethylacetamide, and trichloroethylene have been linked to toxic hepatitis in exposed workers.
- Viral hepatitis predominantly affects healthcare professionals due to potential blood exposure.
Purpose of the Study:
- To review the classification and reported cases of occupational hepatic disorders in Korea.
- To highlight preventive strategies for different types of occupational liver diseases.
- To address the need for further evidence regarding the occupational etiology of hepatocellular carcinoma.
Main Methods:
- Review of reported occupational hepatic disorder cases in Korea.
- Analysis of causal links between specific chemical exposures and liver conditions.
- Evaluation of current preventive measures and their effectiveness.
Main Results:
- Toxic hepatitis cases identified in workers exposed to specific solvents.
- Viral hepatitis prevalent among healthcare workers, necessitating vaccination and monitoring.
- Hepatic angiosarcoma due to vinyl chloride monomer (VCM) exposure, though not yet officially reported in Korea.
- Hepatocellular carcinoma cases compensated due to overwork/stress, but lacking robust scientific evidence of causality.
Conclusions:
- Pre-placement medical examinations and regular follow-ups are essential for preventing toxic hepatitis.
- Vaccination and serum monitoring are key preventive strategies for viral hepatitis in healthcare workers.
- Further research is required to establish the causal relationship between occupational factors like overwork/stress and hepatocellular carcinoma.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...